Pulmonary drugs are medications used for treating various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and other lung infections. This class of drugs includes anti-asthmatics, bronchodilators, anti-inflammatory drugs, leukotriene antagonists, and combinations of multiple drugs. Pulmonary drugs provide relief from symptoms such as cough, wheezing, shortness of breath and improve lung capacity.

The global Pulmonary Drugs Market is ... Read more

Pulmonary drugs are medications intended for treatment of respiratory diseases and disorders affecting the lungs. Increased prevalence of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, and cystic fibrosis have created massive demand for pulmonary drugs globally.

The global pulmonary drugs market is estimated to be valued at US$ 3.93 Bn in 2024 and is expected to exhibit a CAGR of 7.5% over the ... Read more